Tate & Lyle plc (LON:TATE – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 650 and last traded at GBX 552, with a volume of 138464141 shares. The stock had previously closed at GBX 505.93.
Analysts Set New Price Targets
A number of equities analysts have commented on TATE shares. Berenberg Bank raised their price objective on Tate & Lyle from GBX 464 to GBX 554 and gave the stock a “hold” rating in a research note on Wednesday, May 27th. Deutsche Bank Aktiengesellschaft upgraded Tate & Lyle to a “buy” rating and upped their target price for the company from GBX 460 to GBX 595 in a research report on Friday, May 15th. Finally, UBS Group restated a “neutral” rating and issued a GBX 375 price target on shares of Tate & Lyle in a research report on Monday, May 18th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of GBX 516.
Read Our Latest Report on TATE
Tate & Lyle Stock Performance
Tate & Lyle (LON:TATE – Get Free Report) last announced its quarterly earnings data on Thursday, May 21st. The company reported GBX 22 earnings per share (EPS) for the quarter. Tate & Lyle had a net margin of 4.84% and a return on equity of 6.17%. The business had revenue of GBX 200.60 billion for the quarter. As a group, equities analysts predict that Tate & Lyle plc will post 51.3392857 earnings per share for the current year.
Tate & Lyle Company Profile
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers dairy products, soups, sauces, and dressings; bakery products and snacks; texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; fibres; and stabilizers and functional systems.
Further Reading
- Five stocks we like better than Tate & Lyle
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.
